4,340
Views
12
CrossRef citations to date
0
Altmetric
Short Communication

Mycotic infections – mucormycosis and oral candidiasis associated with Covid-19: a significant and challenging association

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 1967699 | Received 23 Jun 2021, Accepted 10 Aug 2021, Published online: 26 Aug 2021

References

  • Riad A, Klugar M, Krsek M. COVID-19-related oral manifestations: early disease features? Oral Dis. 2020. DOI:https://doi.org/10/1111/odi.13516
  • Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021;9(3):523.
  • Prakash H, Chakrabart IA. Global epidemiology of Mucormycosis. J Fungi (Basel). 2019;5(1):26.
  • ICMR GUIDELINES: EVIDENCE BASED ADVISORY IN THE TIME OF COVID-19 (Screening, Diagnosis & Management of Mucormycosis). 2021; [cited 2021 Jun 17]. Avialable from: https://www.icmr.gov.in/pdf/covid/techdoc/Mucormycosis_ADVISORY-FROM-ICMR-In-COVID19
  • Jerônimo LS, Abreu LG, Cunha FA, et al. Association between periodontitis and nosocomial pneumonia: a systematic review and meta-analysis of observational studies. Oral Health Prev Dent. 2020;18(1):11–5.
  • Antinori S, Milazzo L, Sollima S, et al. Candidemia and invasive candidiasis in adults: a narrative review. Eur J Intern Med. 2016;34:21–28.
  • Salehi M, Ahmadikia K, Mahmoudi S, et al. Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: species identification and antifungal susceptibility pattern. Mycoses. 2020;63(8):771–778.
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
  • Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective for prevention. Respir Care. 2005;50(6):725–741. PMID: 15913465
  • Williams D, Lewis M. Pathogenesis and treatment of oral candidosis. J Oral Microbiol. 2011;3:5771.
  • Rajendra SAB, Muddana K, Bakki SR. Fungal infections of oral cavity: diagnosis, management, and association with COVID-19. SN Comp Clin Med. 2021;27:1–12. Epub ahead of print. PMID: 33817556; PMCID: PMC8003891.
  • Acharya S, Lohe VK, Bhowate RR. Diagnosis and management of pseudomembranous candidiasis. J Otolaryngol ENT Res. 2017;8(3):00249.
  • Riad A, Gomaa E, Hockova B, et al. Oral candidiasis of COVID-19 patients: case report and review of evidence. J Cosmet Dermatol. 2021;20(6):1580–1584. Epub 2021 Mar 21. PMID: 33713390
  • Amorim DSJ, Normando AGC, Carvalho SRL, et al. Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations? Int J Infect Dis. 2020;97:326–328. Epub 2020 Jun 9. PMID: 32526392; PMCID: PMC7280113.
  • Baraboutis IG, Gargalianos P, Aggelonidou E, et al. Initial real-life experience from a designated COVID-19 centre in athens, greece: a proposed therapeutic algorithm. SN Compreh Clin Med. 2020:1–5. DOI:https://doi.org/10.1007/s42399-020-00324-x. Advance online publication.
  • Rodr´ıguez. MD, Romera JA, Villarroel M. Oral manifestations associated to Covid-19. Oral Dis. 2020. DOI:https://doi.org/10.1111/odi.13555
  • Dima M, Enatescu I, Craina M, et al. First neonates with severe acute respiratory syndrome coronavirus 2 infection in Romania: three case reports. Medicine (Baltimore). 2020;99(33):e21284.
  • Corchuelo J, Ulloa FC. Oral manifestations in a patient with a history of asymptomatic COVID-19: case report. Int J Infect Dis. 2020;100:154–157. Epub 2020 Sep 1. PMID: 32882435; PMCID: PMC7462545
  • Hockova B, Riad A, Valky J, et al. Oral Complications of ICU patients with COVID-19: case series and review of two hundred and ten cases. J Clin Med. 2021;10:581.
  • Vijay S, Bansal N, Rao BK, et al. Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect Drug Resist. 2021;14:1893–1903.
  • Riad A, Gad A, Hockova B, et al. Oral candidiasis in non-severe COVID-19 patients: call for antibiotic stewardship. Oral Surg. 2020;21. PMID: 33042219; PMCID: PMC7537301. DOI:https://doi.org/10.1111/ors.12561.